Home
INDV
INDV News

Latest Indivior PLC (INDV) News on November 17, 2024

Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior

PR Newswire

10 days ago

Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior

Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month

PR Newswire

18 days ago

Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month

Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Competitive ...

GuruFocus.com

23 days ago

Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Competitive ...

Indivior PLC (INDV) Surpasses Q3 Earnings and Revenue Estimates

Zacks

24 days ago

Indivior PLC (INDV) Surpasses Q3 Earnings and Revenue Estimates

Indivior Announces Q3 2024 Financial Results

PR Newswire

24 days ago

Indivior Announces Q3 2024 Financial Results

Indivior PLC (INDV) Q3 2024 Earnings Report Preview: What to Expect

GuruFocus.com

25 days ago

Indivior PLC (INDV) Q3 2024 Earnings Report Preview: What to Expect

Two Seas Capital LP Increases Stake in Indivior PLC

GuruFocus.com

a month ago

Two Seas Capital LP Increases Stake in Indivior PLC

Indivior price target lowered to $16 from $20 at Craig-Hallum

TipRanks

a month ago

Indivior price target lowered to $16 from $20 at Craig-Hallum

Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Navigating Competitive Pressures and ...

GuruFocus.com

a month ago

Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Navigating Competitive Pressures and ...

Indivior Cuts 2024 Outlook As Competition And Market Pressures Weigh On SUBLOCADE: Details

Benzinga

a month ago

Indivior Cuts 2024 Outlook As Competition And Market Pressures Weigh On SUBLOCADE: Details

MT Newswires

a month ago

Indivior Shares Fall Pre-Bell After Lowering Fiscal Year 2024 Revenue Outlook

Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion

PR Newswire

a month ago

Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion

MT Newswires

a month ago

Indivior Gets FDA Priority Review on Prior Approval Supplement for Sublocade

Indivior's SUBLOCADE® Rapid Induction/Alternative Injection Site Prior Approval Supplement (PAS) Receives FDA Priority Review

PR Newswire

a month ago

Indivior's SUBLOCADE® Rapid Induction/Alternative Injection Site Prior Approval Supplement (PAS) Receives FDA Priority Review

Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript Highlights: Key Financials and ...

GuruFocus.com

2 months ago

Addex Therapeutics Ltd (ADXN) Q2 2024 Earnings Call Transcript Highlights: Key Financials and ...

Rigel (RIGL) Surges 19.7%: Is This an Indication of Further Gains?

Zacks

2 months ago

Rigel (RIGL) Surges 19.7%: Is This an Indication of Further Gains?

Top 3 Health Care Stocks That May Explode This Month

Benzinga

2 months ago

Top 3 Health Care Stocks That May Explode This Month

Indivior Provides Update on Aelis Farma's Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder

PR Newswire

2 months ago

Indivior Provides Update on Aelis Farma's Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder

Addex Stock Soars on Crucial Update From Indivior Research Deal

Zacks

3 months ago

Addex Stock Soars on Crucial Update From Indivior Research Deal

Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder

Benzinga

3 months ago

Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder

MT Newswires

3 months ago

Indivior Says BARDA Makes 1st Order of Opioid Overdose Reversal Nasal Spray

Indivior Announces BARDA's First Order of OPVEE® to Combat Opioids and Aid in National Preparedness

PR Newswire

3 months ago

Indivior Announces BARDA's First Order of OPVEE® to Combat Opioids and Aid in National Preparedness

MT Newswires

4 months ago

Indivior to Pay $86 Million in Multistate Opioid Settlement, New York Attorney General Says

Indivior reaches $86 million opioid settlement with 16 US states

Reuters

4 months ago

Indivior reaches $86 million opioid settlement with 16 US states

MT Newswires

4 months ago

Indivior Shares Rise After Q2 Adjusted Earnings, Revenue Rise

Indivior PLC (INDV) Q2 Earnings and Revenues Beat Estimates

Zacks

4 months ago

Indivior PLC (INDV) Q2 Earnings and Revenues Beat Estimates

Indivior Announces a New $100 Million Share Repurchase Program; New Program will be Executed Over an Accelerated Time Frame

PR Newswire

4 months ago

Indivior Announces a New $100 Million Share Repurchase Program; New Program will be Executed Over an Accelerated Time Frame

Indivior Announces Q2 2024 Financial Results

PR Newswire

4 months ago

Indivior Announces Q2 2024 Financial Results

Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for

Zacks

4 months ago

Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for

Analysts Estimate Indivior PLC (INDV) to Report a Decline in Earnings: What to Look Out for

Zacks

4 months ago

Analysts Estimate Indivior PLC (INDV) to Report a Decline in Earnings: What to Look Out for

Indivior (INDV) Down on Dropping Schizophrenia Drug, Cuts '24 View

Zacks

4 months ago

Indivior (INDV) Down on Dropping Schizophrenia Drug, Cuts '24 View

MT Newswires

4 months ago

Sector Update: Health Care

MT Newswires

4 months ago

Top Premarket Decliners

MT Newswires

4 months ago

Indivior Lowers Fiscal 2024 Net Revenue Guidance, to Discontinue Antipsychotic Injection Perseris -- Shares Tumble Premarket

Indivior Provides Business Update; Conference Call at 8:00 AM U.S. EDT

PR Newswire

4 months ago

Indivior Provides Business Update; Conference Call at 8:00 AM U.S. EDT

Pulling back 10% this week, Indivior's LON:INDV) five-year decline in earnings may be coming into investors focus

Simply Wall St.

4 months ago

Pulling back 10% this week, Indivior's LON:INDV) five-year decline in earnings may be coming into investors focus

Indivior CEO Expects Ongoing U.S. Opioid Crisis to Drive Sales Growth

The Wall Street Journal

4 months ago

Indivior CEO Expects Ongoing U.S. Opioid Crisis to Drive Sales Growth

Indivior Announces the Publication of New Data on the Comparative Effectiveness of Intranasal (IN) Nalmefene (OPVEE 2.7mg) and IN Naloxone (4 mg) in a Translational Model Assessing the Impact of a Synthetic Opioid Overdose on Respiratory Depression and Cardiac Arrest

PR Newswire

5 months ago

Indivior Announces the Publication of New Data on the Comparative Effectiveness of Intranasal (IN) Nalmefene (OPVEE 2.7mg) and IN Naloxone (4 mg) in a Translational Model Assessing the Impact of a Synthetic Opioid Overdose on Respiratory Depression and Cardiac Arrest

Indivior Announces Dosing of First Subject with INDV-2000 in a Phase 2 Study Assessing the Safety and Efficacy of INDV-2000 in Individuals with Opioid Use Disorder

PR Newswire

5 months ago

Indivior Announces Dosing of First Subject with INDV-2000 in a Phase 2 Study Assessing the Safety and Efficacy of INDV-2000 in Individuals with Opioid Use Disorder

With 59% ownership, Indivior PLC (LON:INDV) boasts of strong institutional backing

Simply Wall St.

6 months ago

With 59% ownership, Indivior PLC (LON:INDV) boasts of strong institutional backing

Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance

PR Newswire

6 months ago

Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance

GuruFocus.com

7 months ago

Indivior PLC (INDV) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ...

Why Indivior PLC (LON:INDV) Looks Like A Quality Company

Simply Wall St.

7 months ago

Why Indivior PLC (LON:INDV) Looks Like A Quality Company

Indivior PLC (INDV) Q1 Earnings and Revenues Lag Estimates

Zacks

7 months ago

Indivior PLC (INDV) Q1 Earnings and Revenues Lag Estimates

Reuters

7 months ago

UPDATE 1-UK-listed drugmaker Indivior seeks shareholder nod for US listing

Reuters

7 months ago

Drugmaker Indivior to seek shareholder nod on shifting primary listing to US

Indivior Confirms Plan to Switch Listing From London to New York

Bloomberg

7 months ago

Indivior Confirms Plan to Switch Listing From London to New York

Indivior Announces Q1 2024 Financial Results

PR Newswire

7 months ago

Indivior Announces Q1 2024 Financial Results

Indivior (INDV) Surges 5.6%: Is This an Indication of Further Gains?

Zacks

7 months ago

Indivior (INDV) Surges 5.6%: Is This an Indication of Further Gains?

Indivior PLC (INDV) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Zacks

8 months ago

Indivior PLC (INDV) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone

PR Newswire

8 months ago

Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone

Vanda (VNDA) Falls on FDA's CRL to Hetlioz sNDA for Insomnia

Zacks

8 months ago

Vanda (VNDA) Falls on FDA's CRL to Hetlioz sNDA for Insomnia

Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata

Zacks

8 months ago

Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata

Zacks.com featured highlights Modine Manufacturing, Indivior and Interface

Zacks

8 months ago

Zacks.com featured highlights Modine Manufacturing, Indivior and Interface

Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat

Zacks

8 months ago

Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat

Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why

Zacks

8 months ago

Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why

Mirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat

Zacks

9 months ago

Mirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat

Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation

PR Newswire

9 months ago

Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation

Earnings Update: Indivior PLC (LON:INDV) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Simply Wall St.

9 months ago

Earnings Update: Indivior PLC (LON:INDV) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Health Care Roundup: Market Talk

The Wall Street Journal

9 months ago

Health Care Roundup: Market Talk

London Risks Losing Another Major Company to New York Stock Exchange

Bloomberg

9 months ago

London Risks Losing Another Major Company to New York Stock Exchange

Fresh blow for London market as drug maker joins exodus to New York

The Telegraph

9 months ago

Fresh blow for London market as drug maker joins exodus to New York

Reuters

9 months ago

UPDATE 2-Drugmaker Indivior consults on moving primary listing from London to US

Reuters

9 months ago

Indivior plans shifting primary listing to U.S.

Indivior Announces Q4 / FY 2023 Financial Results

PR Newswire

9 months ago

Indivior Announces Q4 / FY 2023 Financial Results

Indivior PLC (LON:INDV) Shares Could Be 44% Below Their Intrinsic Value Estimate

Simply Wall St.

9 months ago

Indivior PLC (LON:INDV) Shares Could Be 44% Below Their Intrinsic Value Estimate

Here's Why Merit Medical (MMSI) is a Strong Momentum Stock

Zacks

10 months ago

Here's Why Merit Medical (MMSI) is a Strong Momentum Stock

Malibu Boats (MBUU) Q2 Earnings Beat, Revenues Miss Estimates

Zacks

10 months ago

Malibu Boats (MBUU) Q2 Earnings Beat, Revenues Miss Estimates

Do Acushnet Holdings' (NYSE:GOLF) Earnings Warrant Your Attention?

Simply Wall St.

10 months ago

Do Acushnet Holdings' (NYSE:GOLF) Earnings Warrant Your Attention?

Should You Buy Merit Medical (MMSI) After Golden Cross?

Zacks

10 months ago

Should You Buy Merit Medical (MMSI) After Golden Cross?

Papa Johns Declares Quarterly Dividend

Business Wire

10 months ago

Papa Johns Declares Quarterly Dividend

Nomad Foods Declares Initial Quarterly Dividend

PR Newswire

10 months ago

Nomad Foods Declares Initial Quarterly Dividend

CarGurus Partners with Chase to Expand Consumer Financing Options

GlobeNewswire

10 months ago

CarGurus Partners with Chase to Expand Consumer Financing Options

Maine Virtual Academy Now Accepting Enrollments for 2024-2025 School Year

Business Wire

10 months ago

Maine Virtual Academy Now Accepting Enrollments for 2024-2025 School Year

Dow Jones Reverses As Intel Plunges On Earnings; Cathie Wood Loads Up As Tesla Dives

Investor's Business Daily

10 months ago

Dow Jones Reverses As Intel Plunges On Earnings; Cathie Wood Loads Up As Tesla Dives

Community Bank System Inc. Reports Mixed Results Amidst Challenging Environment

GuruFocus.com

10 months ago

Community Bank System Inc. Reports Mixed Results Amidst Challenging Environment

Why sweet treats are increasingly expensive

The Economist

10 months ago

Why sweet treats are increasingly expensive

IFF to Release Fourth Quarter and Full Year 2023 Results on Feb. 20, 2024; IFF to Present at 2024 CAGNY Conference on Feb. 22, 2024

Business Wire

10 months ago

IFF to Release Fourth Quarter and Full Year 2023 Results on Feb. 20, 2024; IFF to Present at 2024 CAGNY Conference on Feb. 22, 2024

18 High Growth Low PE Stocks

Insider Monkey

10 months ago

18 High Growth Low PE Stocks

Why Macy’s rejected its $5.8 billion buyout bid — and what’s next

Yahoo Finance

10 months ago

Why Macy’s rejected its $5.8 billion buyout bid — and what’s next

Envestnet Launches RIA Growth Lab - A Consulting Capability Led by Industry Veteran Dani Fava

PR Newswire

10 months ago

Envestnet Launches RIA Growth Lab - A Consulting Capability Led by Industry Veteran Dani Fava

Dividend Challengers List Ranked By Yield: Top 30

Insider Monkey

10 months ago

Dividend Challengers List Ranked By Yield: Top 30

Blackstone to take Tricon Residential private for $3.5 billion

Reuters

10 months ago

Blackstone to take Tricon Residential private for $3.5 billion

3 Consumer Stocks to Sell in January Before They Crash and Burn

InvestorPlace

10 months ago

3 Consumer Stocks to Sell in January Before They Crash and Burn

Federated Hermes (FHI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

10 months ago

Federated Hermes (FHI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Business Wire

10 months ago

RH Announces the Appointment of Jarrett Stuhl as Chief Real Estate & Development Officer

A.O. Smith (AOS) is a Top-Ranked Momentum Stock: Should You Buy?

Zacks

10 months ago

A.O. Smith (AOS) is a Top-Ranked Momentum Stock: Should You Buy?

Methanex Corporation to Speak at the 27th Annual CIBC Western Institutional Investor Conference

GlobeNewswire

10 months ago

Methanex Corporation to Speak at the 27th Annual CIBC Western Institutional Investor Conference

Will Scorpio Tankers (STNG) Beat Estimates Again in Its Next Earnings Report?

Zacks

10 months ago

Will Scorpio Tankers (STNG) Beat Estimates Again in Its Next Earnings Report?

Billionaire Ryan Cohen’s Meme-Stock Mystique Fizzles After Alibaba’s Bad Year

Bloomberg

10 months ago

Billionaire Ryan Cohen’s Meme-Stock Mystique Fizzles After Alibaba’s Bad Year

Scorpio Tankers Inc. Announces an Agreement to Sell an MR Product Tanker and the Exercise of Purchase Options on Five Ships

GlobeNewswire

10 months ago

Scorpio Tankers Inc. Announces an Agreement to Sell an MR Product Tanker and the Exercise of Purchase Options on Five Ships

Market Miracles: 3 Stocks Ready for an Unprecedented Rally

InvestorPlace

10 months ago

Market Miracles: 3 Stocks Ready for an Unprecedented Rally

Capital Allocation Trends At RH (NYSE:RH) Aren't Ideal

Simply Wall St.

10 months ago

Capital Allocation Trends At RH (NYSE:RH) Aren't Ideal

30 Best Selling Yankee Candle Scents and Alternatives

Insider Monkey

10 months ago

30 Best Selling Yankee Candle Scents and Alternatives

What Makes Northern Oil and Gas (NOG) an Investment Bet?

Insider Monkey

10 months ago

What Makes Northern Oil and Gas (NOG) an Investment Bet?

The Energy Industry Consolidation Wave Hits The Gas Sector With $7 Billion Merger

Investor's Business Daily

10 months ago

The Energy Industry Consolidation Wave Hits The Gas Sector With $7 Billion Merger

The Chesapeake-Southwestern Deal Creates a New Giant for Natural-Gas Exports

The Wall Street Journal

10 months ago

The Chesapeake-Southwestern Deal Creates a New Giant for Natural-Gas Exports

Squarespace (SQSP) Laps the Stock Market: Here's Why

Zacks

10 months ago

Squarespace (SQSP) Laps the Stock Market: Here's Why

Grand Canyon Education, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call Details

PR Newswire

10 months ago

Grand Canyon Education, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call Details

Kohl's (KSS) Strategic Priorities Position it for Growth in 2024

Zacks

10 months ago

Kohl's (KSS) Strategic Priorities Position it for Growth in 2024

Share on Social Networks: